OCLN Cancer Research Results
OCLN, Occludin: Click to Expand ⟱
| Source: |
| Type: |
Occludin
Target/Pathway: Occludin
Abbreviation: OCLN
Category: Tight junction / intestinal barrier
Direction in IBD: usually down
Cancer relevance: usually barrier-loss associated, especially in inflammation-linked colorectal cancer
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, *antiOx↑, *Inflam↓, *Bacteria↓, *hepatoP↑, *cardioP↑, *neuroP↑, *ROS↓, *NF-kB↓, *NRF2↑, *Obesity↓, *GutMicro↑, *AntiAg↑, *cardioP↑, *AntiDiabetic↑, *NLRP3↓, *OCLN↓, *VEGF↓, BioAv↝,
*Inflam↓, *antiOx↑, *CLDN1↓, *OCLN↓, *ZO-1↓, *IL6↓, *IL1β↓, *TNF-α↓, *BAX↓, *BAD↓, *Casp3↓, *Casp8↓, *ROS↓, *SOD↑, *Catalase↑, *GSH↑, *TJ↑, *Apoptosis↓, *NF-kB↓, *MAPK↓,
*neuroP↑, *Aβ↓, *Casp3↑, *ZO-1↓, *CLDN5↓, *OCLN↓, *MMP2↑, *MMP↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1,
Total Targets: 1
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, Catalase↑, 1, GSH↑, 1, NRF2↑, 1, ROS↓, 2, SOD↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 1, BAD↓, 1, BAX↓, 1, Casp3↓, 1, Casp3↑, 1, Casp8↓, 1, MAPK↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1, CLDN1↓, 1, MMP2↑, 1, TJ↑, 1, ZO-1↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
CLDN5↓, 1, VEGF↓, 1,
Barriers & Transport(tgid=15) ⓘ
OCLN↓, 3,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 1, Inflam↓, 2, NF-kB↓, 2, TNF-α↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1, IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, cardioP↑, 2, hepatoP↑, 1, neuroP↑, 2, Obesity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 38
Scientific Paper Hit Count for: OCLN, Occludin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1463 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page